ALTAVERE LABS
LIVE

Serial Number

99704725

Owner

Shankargouda Patil

Attorney

Scott H. Blackman

Filing Date

Mar 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ALTAVERE LABS Trademark

Serial Number: 99704725

ALTAVERE LABS is a trademark filed by Shankargouda Patil on March 16, 2026. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Shankargouda Patil

1433 W Pinyon Pines Way
South Jordan, UT 84095

Entity Type: 01

ALTAVERE LABS, LLC

108 LAKELAND AVE.
DOVER, DE 19901

Entity Type: 16

Trademark Details

Filing Date

March 16, 2026

Registration Date

Not Registered

Goods & Services

Vaccines; Dietary supplements; Nutritional supplements; Vitamin and mineral supplements; Amino acids for nutritional purposes; Probiotic supplements; Prebiotic supplements; Dietetic foods adapted for medical use; Medicated mouthwash; Medicated dental rinses; Medicated toothpaste; Mouthwashes for medical purposes; Dental varnish for use by dentists; Dental cements; Materials for dental fillings; Dental impression materials; Dental adhesives; Hemostatics for medical purposes; Hemostatics for dental purposes; Dental sealants; Wound dressings; Essential oils for aromatherapy use; Pharmaceutical preparations for the treatment and prevention of oral and oropharyngeal cancers; Pharmaceutical preparations for the treatment and prevention of oral potentially malignant disorders, namely, leukoplakia, erythroplakia, and oral submucous fibrosis; Pharmaceutical preparations for the treatment and prevention of periodontal diseases, namely, gingivitis and periodontitis; Medicated preparations for the treatment and prevention of dental caries; Medicated preparations for the treatment and prevention of oral mucositis; Medicated preparations for the treatment and prevention of oral candidiasis and other fungal infections of the oral cavity; Medicated preparations for the treatment and prevention of medication-related osteonecrosis of the jaw (MRONJ); Medicated preparations for the treatment and prevention of temporomandibular joint disorders; Medicated preparations for the treatment and prevention of xerostomia; Medicated preparations for the treatment and prevention of diabetes and metabolic disorders; Medicated preparations for the treatment and prevention of cardiovascular diseases; Medicated preparations for the treatment and prevention of neurodegenerative diseases; Pharmaceutical preparations for the treatment and prevention of autoimmune and inflammatory conditions; Pharmaceutical preparations for the treatment and prevention of bone and joint disorders, namely, osteoporosis and osteoarthritis; Pharmaceutical preparations for the treatment and prevention of infectious diseases; Pharmaceutical preparations for the treatment and prevention of gastrointestinal disorders; Pharmaceutical preparations for the treatment and prevention of respiratory diseases; Pharmaceutical preparations for the treatment and prevention of dermatological conditions; Pharmaceutical preparations for the treatment and prevention of nutritional deficiencies; Pharmaceutical preparations for the treatment and prevention of pain and inflammation; Pharmaceutical preparations for the treatment and prevention of sleep disorders; Pharmaceutical preparations for the treatment and prevention of anxiety and stress-related conditions; Pharmaceutical preparations for the treatment and prevention of immune system disorders; Pharmaceutical preparations for promoting enamel remineralization and strengthening; Pharmaceutical preparations for the treatment of dentinal hypersensitivity; Pharmaceutical preparations for the promotion of oral wound healing; Pharmaceutical preparations for the management of halitosis; Pharmaceutical preparations for the maintenance of oral microbiome balance; Pharmaceutical preparations for prevention and treatment of peri-implant diseases, namely, peri-implantitis; Pharmaceutical preparations for the support for post-surgical oral tissue recovery; Pharmaceutical preparations for promoting gingival tissue regeneration; Pharmaceutical preparations for the management of oral lichen planus; Pharmaceutical preparations for the management of recurrent aphthous ulcers; Pharmaceutical preparations for tooth whitening and stain prevention; Pharmaceutical preparations for general oral and dental hygiene maintenance

Surgical devices and instruments; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Wearable monitors used to measure biometric data for medical use; Body rehabilitation apparatus for medical purposes; Medical imaging apparatus; Dental implants; Orthodontic appliances; Prosthetic instruments for dental purposes; Endodontic apparatus; Medical apparatus and instruments for use in oral and maxillofacial surgical procedures; Medical apparatus and instruments for use in dental diagnostic and imaging procedures; Medical apparatus and instruments for use in endodontic procedures; Medical apparatus and instruments for use in periodontal procedures; Medical apparatus and instruments for use in orthodontic procedures; Medical apparatus and instruments for use in prosthodontic procedures; Medical apparatus and instruments for use in oral cancer screening and detection; Medical apparatus and instruments for use in biopsy and histopathological specimen collection; Medical apparatus and instruments for use in point-of-care diagnostic testing; Medical apparatus and instruments for use in intraoral and extraoral imaging; Medical apparatus and instruments for use in cephalometric and radiographic analysis; Medical apparatus and instruments for use in salivary diagnostics; Medical apparatus and instruments for use in biosensor-based health monitoring procedures

Software as a service (SAAS) services featuring software for use in healthcare and life sciences data analysis; Software as a service (SAAS) services featuring software for clinical decision support; Software as a service (SAAS) services featuring software for analysis of medical images and medical imaging data; Software as a service (SAAS) services featuring software for bioinformatics and computational biology data analysis; Software as a service (SAAS) services featuring software for statistical analysis and simulation tools for drug discovery and molecular design; Software as a service (SAAS) services featuring software for statistical analysis and simulation tools for clinical trial design and optimization; Software as a service (SAAS) services featuring software for electronic health record data analytics; Software as a service (SAAS) services featuring software for remote patient monitoring data analytics; Software as a service (SAAS) services featuring software for medical diagnostic and prognostic analytics; Software as a service (SAAS) services featuring software for genomics and multi-omics data analysis; Providing temporary use of on-line non-downloadable software for managing and analyzing biomedical and clinical research data; Providing temporary use of on-line non-downloadable software for laboratory information management; Application service provider featuring application programming interface (API) software; Design and development of computer software; Computer software consultancy; Cloud computing featuring software for use in healthcare and life sciences data management

Toothpaste; Tooth powder; Non-medicated mouthwashes; Non-medicated mouth rinse; Breath freshening preparations for personal hygiene; Tooth whitening preparations; Dental bleaching gel; Preparations for cleaning dentures; Cosmetic preparations for the care of mouth and teeth; Non-medicated body care preparations, namely, creams, lotions, gels, and serums; Non-medicated hair care preparations, namely, shampoos, conditioners, and hair lotions

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 7, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2026 CNRT
ASSIGNED TO EXAMINER
Jul 18, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2026 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 3, 2026 ASGN
APPLICATION FILING RECEIPT MAILED
Mar 16, 2026 MAFR
NEW APPLICATION ENTERED
Mar 16, 2026 NWAP